Hikma Pharmaceutical | HIK - Market Capitalization


Hikma Pharmaceutical reported $2.9B in Market Capitalization this April of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Almirall EUR 2.76B 472.53M Dec/2025
argenx SE USD 51.83B 7.52B Dec/2025
AstraZeneca USD 288.15B 55.08B Dec/2025
Bayer EUR 36.36B 9.13B Dec/2025
Fresenius EUR 27.59B 889.91M Dec/2025
Galapagos EUR 1.85B 76.44M Dec/2025
Genmab DKK 20.48B 1.02B Dec/2025
GlaxoSmithKline GBP 74.36B 10.31B Dec/2025
Hikma Pharmaceutical USD 4.63B 1.42B Dec/2025
Lonza CHF 39.68B 980.61M Jun/2025
Merck EUR 53.3B 5.72B Dec/2025
Orion EUR 8.94B 243.74M Dec/2025
Recordati EUR 10.15B 660.84M Dec/2025
Roche Holding CHF 266.34B 55.46B Dec/2025
Sanofi EUR 100.88B 4.46B Dec/2025
UCB EUR 46.41B 13.94B Dec/2025